Release Notes: Version 20210507
About this release
This release (version 20210507) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
Scientific Notation
Scientific notation has been incorporated into CCDD with this release for numbers greater than 1 billion (1e9). As a result, the ingredient strength for 1 existing MP and 1 existing NTP will now be expressed in scientific notation.
| mp_code | mp-formal_name | FORMER mp_formal_name | ntp code | ntp_formal_name | FORMER ntp_formal_name |
|---|---|---|---|---|---|
| 02512947 | COVISHIELD (ChAdOx1-S (recombinant) 5e10 vp per 0.5 mL solution for injection 5 mL vial) VERITY PHARMACEUTICALS INC. | COVISHIELD (ChAdOx1-S (recombinant) 50000000000 vp per 0.5 mL solution for injection 5 mL vial) VERITY PHARMACEUTICALS INC. | 9014470 | ChAdOx1-S (recombinant) 5e10 vp per 0.5 mL solution for injection 5 mL vial) | ChAdOx1-S (recombinant) 50000000000 vp per 0.5 mL solution for injection 5 mL vial |
Nonproprietary Therapeutic Product (NTP)
There is 1 new deprecated concept in this version. The dosage form of the corresponding products changed in DPD.
| ntp_code | ntp_formal_name | ntp_fr_description | Type of change | Replaced by ntp_code | Replaced by ntp_formal_name | Replaced by ntp_fr_description |
|---|---|---|---|---|---|---|
| 9004168 | white petrolatum 100 % cutaneous gel | pétrolatum blanc 100 % gel cutané | Concept deprecated | 9001536 | white petrolatum 100 % cutaneous ointment | pétrolatum blanc 100 % pommade cutanée |
Manufactured Product (MP)
There is 1 new deprecated concept in this version. The code for the corresponding MP needed to be changed due to the addition of a second presentation (vial size) for the same DIN.
| mp_code | mp_formal_name | mp_fr_description | Type of change | Replaced by mp_code | mp_formal_name | mp_fr_description |
|---|---|---|---|---|---|---|
| 00587737 | HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC | HUMULIN N (insuline isophane humaine 100 unité par mL suspension injectable 10 mL fiole) ELI LILLY CANADA INC | Concept deprecated | 77701034 | HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC | HUMULIN N (insuline isophane humaine 100 unité par mL suspension injectable 10 mL fiole) ELI LILLY CANADA INC |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]